FDA Approves Tivdak for Metastatic Cervical Cancer
The Food and Drug Administration approved Tivdak for metastatic cervical cancer that progressed on or after chemotherapy.
The Food and Drug Administration approved Tivdak for metastatic cervical cancer that progressed on or after chemotherapy.
Dr. Murugesan Manoharan of Miami Cancer Institute and Baptist Health South Florida shares key questions patients who have received a diagnosis of bladder cancer should…
Aim To explore the experiences, expectations and needs of mothers from low-socioeconomic status at 1 month postpartum. Design Descriptive qualitative. Methods Mothers from low-socioeconomic stat…
Read about how the NHS Long Term Workforce Plan set out the scale of the workforce shortage that the NHS is facing over the coming…
We want to hear your story! Submit your entry to the Nursing Times Awards and join us at a glittering ceremony on Wednesday 23 October…
A breakthrough therapy designation was granted to petosemtamab by the FDA to treat patients with recurrent or metastatic head and neck cancers.
Read about the work of Northern Ireland’s only nurse hysteroscopist and why she wants more investment in the role.
To improve care delivery for patients diagnosed with head and neck cancers, ACCC with the Head and Neck Cancer Alliance has launched an educational initiative…
Read tributes from the nursing profession to Dame Professor Elizabeth Fradd, who has died at the age of 75.
The Nursing Times Workforce Summit & Awards is a collaborative effort with the sector, bringing together expertise in workforce planning and real-world case studies. Its…
Commentary on: Aspinall C, Slark J, Parr J, et al . The role of healthcare leaders in implementing equitable clinical academic pathways for nurses: An…